HeartBeam (BEAT) Financials

HeartBeam logo
$0.33 -0.03 (-7.02%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$0.35 +0.02 (+4.85%)
As of 07:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for HeartBeam

Annual Income Statements for HeartBeam

This table shows HeartBeam's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-1.07 -4.43 -13 -15 -19 -21
Consolidated Net Income / (Loss)
-1.07 -4.43 -13 -15 -19 -21
Net Income / (Loss) Continuing Operations
-1.07 -4.43 -13 -15 -19 -21
Total Pre-Tax Income
-1.07 -4.43 -13 -15 -19 -21
Total Operating Income
-0.79 -2.29 -13 -15 -20 -21
Total Gross Profit
0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue
0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
0.79 2.29 13 15 20 21
Selling, General & Admin Expense
0.66 2.03 7.35 8.52 8.84 7.69
Research & Development Expense
0.13 0.26 5.68 6.80 11 13
Total Other Income / (Expense), net
-0.28 -2.14 0.07 0.68 0.44 0.12
Interest & Investment Income
- -2.17 0.07 0.68 0.45 0.12
Other Income / (Expense), net
0.00 0.02 0.00 0.00 -0.01 0.00
Income Tax Expense
0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share
($0.29) ($1.03) ($1.59) ($0.72) ($0.73) ($0.62)
Weighted Average Basic Shares Outstanding
3.65M 4.28M 8.17M 20.33M 26.65M 33.71M
Diluted Earnings per Share
($0.29) ($1.03) ($1.59) ($0.72) ($0.73) ($0.62)
Weighted Average Diluted Shares Outstanding
3.65M 4.28M 8.17M 20.33M 26.65M 33.71M
Weighted Average Basic & Diluted Shares Outstanding
- 7.96M 8.23M 26.33M 33.73M 41.09M

Quarterly Income Statements for HeartBeam

This table shows HeartBeam's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-4.61 -4.96 -4.98 -4.91 -5.48 -4.97 -5.26 -5.30 -4.70 -5.04 -3.01
Consolidated Net Income / (Loss)
-4.61 -4.96 -4.98 -4.91 -5.48 -4.97 -5.26 -5.30 -4.70 -5.04 -3.01
Net Income / (Loss) Continuing Operations
-4.61 -4.96 -4.98 -4.91 -5.48 -4.97 -5.26 -5.30 -4.70 -5.04 -3.01
Total Pre-Tax Income
-4.61 -4.96 -4.98 -4.91 -5.48 -4.97 -5.26 -5.30 -4.70 -5.04 -3.01
Total Operating Income
-4.78 -5.09 -5.07 -4.94 -5.50 -5.04 -5.29 -5.31 -4.72 -5.09 -3.46
Total Gross Profit
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Revenue
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Cost of Revenue
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Operating Expenses
4.78 5.09 5.07 4.94 5.50 5.04 5.29 5.31 4.72 5.09 3.46
Selling, General & Admin Expense
2.36 2.25 2.18 2.06 2.01 1.71 2.01 1.95 2.35 2.76 1.34
Research & Development Expense
2.43 2.84 2.89 2.89 3.49 3.33 3.28 3.35 2.37 2.33 2.12
Total Other Income / (Expense), net
0.18 0.13 0.09 0.04 0.02 0.06 0.04 0.01 0.02 0.05 0.45
Interest & Investment Income
0.18 0.13 0.10 0.04 0.02 0.06 0.04 0.00 0.02 0.05 0.06
Other Income / (Expense), net
- - - - - - -0.00 - - - 0.38
Income Tax Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Basic Earnings per Share
($0.17) ($0.19) ($0.19) ($0.18) ($0.18) ($0.15) ($0.15) ($0.14) ($0.12) ($0.10) ($0.05)
Weighted Average Basic Shares Outstanding
26.51M 26.57M 26.75M 26.65M 30.38M 33.83M 34.40M 33.71M 40.59M 52.77M 57.20M
Diluted Earnings per Share
($0.17) ($0.19) ($0.19) ($0.18) ($0.18) ($0.15) ($0.15) ($0.14) ($0.12) ($0.10) ($0.05)
Weighted Average Diluted Shares Outstanding
26.51M 26.57M 26.75M 26.65M 30.38M 33.83M 34.40M 33.71M 40.59M 52.77M 57.20M
Weighted Average Basic & Diluted Shares Outstanding
26.33M 26.56M 26.67M 33.73M 33.81M 34.31M 34.44M 41.09M 55.51M 56.35M 63.31M

Annual Cash Flow Statements for HeartBeam

This table details how cash moves in and out of HeartBeam's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.02 13 -9.60 13 -14 2.00
Net Cash From Operating Activities
-0.60 -3.23 -9.95 -12 -14 -14
Net Cash From Continuing Operating Activities
-0.60 -3.23 -9.95 -12 -14 -14
Net Income / (Loss) Continuing Operations
-1.07 -4.43 -13 -15 -19 -21
Consolidated Net Income / (Loss)
-1.07 -4.43 -13 -15 -19 -21
Depreciation Expense
- - - 0.00 0.01 0.04
Non-Cash Adjustments To Reconcile Net Income
0.26 2.33 1.12 3.21 4.30 5.37
Changes in Operating Assets and Liabilities, net
0.18 -1.14 1.89 -0.66 0.67 1.61
Net Cash From Investing Activities
0.00 0.00 0.00 -0.26 -0.20 -0.60
Net Cash From Continuing Investing Activities
0.00 0.00 0.00 -0.26 -0.20 -0.60
Purchase of Property, Plant & Equipment
- - 0.00 -0.26 -0.20 -0.60
Purchase of Investments
- - - - 0.00 -3.76
Sale and/or Maturity of Investments
- - - - 0.00 3.76
Net Cash From Financing Activities
0.62 16 0.35 25 0.87 17
Net Cash From Continuing Financing Activities
0.62 16 0.35 25 0.87 17
Issuance of Common Equity
0.00 15 0.35 25 0.73 17
Other Financing Activities, net
- 0.00 0.00 0.23 0.14 0.01
Cash Income Taxes Paid
0.00 0.00 0.00 0.00 0.00 0.00

Quarterly Cash Flow Statements for HeartBeam

This table details how cash moves in and out of HeartBeam's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-3.55 -3.48 -3.39 -3.39 2.01 -1.13 -1.40 2.52 -2.34 6.68 -2.66
Net Cash From Operating Activities
-3.46 -3.55 -3.31 -4.15 -4.48 -3.45 -3.16 -2.91 -3.61 -3.34 -2.59
Net Cash From Continuing Operating Activities
-3.46 -3.55 -3.31 -4.15 -4.48 -3.45 -3.16 -2.91 -3.61 -3.34 -2.59
Net Income / (Loss) Continuing Operations
-4.61 -4.96 -4.98 -4.91 -5.48 -4.97 -5.26 -5.30 -4.70 -5.04 -3.01
Consolidated Net Income / (Loss)
-4.61 -4.96 -4.98 -4.91 -5.48 -4.97 -5.26 -5.30 -4.70 -5.04 -3.01
Depreciation Expense
0.00 - - 0.01 0.01 0.01 0.01 0.02 0.02 0.06 0.07
Non-Cash Adjustments To Reconcile Net Income
1.21 1.04 1.05 1.00 1.11 1.18 1.43 1.65 1.22 2.31 1.35
Changes in Operating Assets and Liabilities, net
-0.06 0.37 0.62 -0.25 -0.11 0.34 0.65 0.73 -0.15 -0.67 -0.99
Net Cash From Investing Activities
-0.09 -0.01 -0.10 - -3.76 1.86 1.72 -0.42 -0.25 -0.25 -0.07
Net Cash From Continuing Investing Activities
-0.09 -0.01 -0.10 - -3.76 1.86 1.72 -0.42 -0.25 -0.25 -0.07
Purchase of Property, Plant & Equipment
-0.09 -0.01 -0.10 - -0.00 -0.10 -0.08 -0.42 -0.25 -0.25 -0.07

Annual Balance Sheets for HeartBeam

This table presents HeartBeam's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
0.05 14 4.04 17 3.28 5.84
Total Current Assets
0.05 14 4.04 17 2.77 4.69
Cash & Equivalents
0.02 13 3.59 16 2.38 4.38
Inventories, net
- - - - 0.00 0.10
Prepaid Expenses
0.03 0.81 0.45 0.64 0.39 0.20
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.26 0.45 1.10
Total Noncurrent Assets
0.00 0.00 0.00 0.05 0.06 0.06
Other Noncurrent Operating Assets
- - 0.00 0.05 0.06 0.06
Total Liabilities & Shareholders' Equity
0.05 14 4.04 17 3.28 5.84
Total Liabilities
4.84 0.59 1.67 1.19 1.62 3.24
Total Current Liabilities
4.84 0.59 1.67 1.19 1.62 3.24
Accounts Payable
0.49 0.59 1.67 0.56 0.53 1.05
Accrued Expenses
- - - 0.64 1.09 2.19
Total Noncurrent Liabilities
0.00 0.00 0.00 0.00 0.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-4.79 13 2.37 16 1.65 2.60
Total Preferred & Common Equity
-4.79 13 2.37 16 1.65 2.60
Preferred Stock
- 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-4.79 13 2.37 16 1.65 2.60
Common Stock
0.01 23 25 53 58 80
Retained Earnings
-4.80 -9.22 -22 -37 -56 -77

Quarterly Balance Sheets for HeartBeam

This table presents HeartBeam's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
14 10 6.66 9.11 5.98 2.88 3.93 11 7.87
Total Current Assets
13 9.70 6.14 8.61 5.36 2.13 2.44 9.00 6.30
Cash & Equivalents
13 9.16 5.77 4.39 3.26 1.86 2.04 8.72 6.07
Inventories, net
- - - - - - 0.13 0.11 0.11
Prepaid Expenses
0.60 0.54 0.38 0.46 0.31 0.27 0.26 0.16 0.12
Plant, Property, & Equipment, net
0.34 0.37 0.46 0.44 0.56 0.69 1.44 1.58 1.52
Total Noncurrent Assets
0.05 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06
Other Noncurrent Operating Assets
0.05 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06
Total Liabilities & Shareholders' Equity
14 10 6.66 9.11 5.98 2.88 3.93 11 7.87
Total Liabilities
1.10 1.42 1.86 1.58 1.80 2.47 3.29 2.46 1.36
Total Current Liabilities
1.10 1.42 1.86 1.58 1.80 2.47 3.29 2.46 1.36
Accounts Payable
1.10 1.42 1.86 0.52 0.81 1.02 0.75 0.61 0.27
Accrued Expenses
- - - 1.06 0.99 1.45 2.55 1.85 1.09
Total Noncurrent Liabilities
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
13 8.71 4.80 7.53 4.18 0.41 0.64 8.18 6.51
Total Preferred & Common Equity
13 8.71 4.80 7.53 4.18 0.41 0.64 8.18 6.51
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
13 8.71 4.80 7.53 4.18 0.41 0.64 8.18 6.51
Common Stock
54 55 56 69 71 72 83 95 97
Retained Earnings
-41 -46 -51 -62 -67 -72 -82 -87 -90

Annual Metrics And Ratios for HeartBeam

This table displays calculated financial ratios and metrics derived from HeartBeam's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 7,809,912.00 8,004,620.00 26,311,904.00 26,665,470.00 34,443,563.00
DEI Adjusted Shares Outstanding
0.00 7,809,912.00 8,004,620.00 26,311,904.00 26,665,470.00 34,443,563.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -0.57 -1.62 -0.56 -0.73 -0.61
Growth Metrics
- - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
0.00% -197.76% -475.70% -17.55% -29.86% -6.08%
EBIT Growth
0.00% -187.18% -475.70% -17.55% -29.91% -6.25%
NOPAT Growth
0.00% -189.97% -470.28% -17.52% -29.86% -6.30%
Net Income Growth
0.00% -314.61% -192.73% -12.94% -32.85% -8.06%
EPS Growth
0.00% -255.17% -54.37% 54.72% -1.39% 15.07%
Operating Cash Flow Growth
0.00% -438.33% -207.99% -21.56% -19.66% 3.34%
Free Cash Flow Firm Growth
0.00% 0.00% -229.56% -52.11% -15.08% -2.18%
Invested Capital Growth
0.00% 142.41% -659.63% 79.34% -186.90% -145.78%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% -22.54% -2.48% -4.38% -1.70%
EBIT Q/Q Growth
0.00% 0.00% -22.54% -2.48% -4.42% -1.74%
NOPAT Q/Q Growth
0.00% 0.00% -22.56% -2.48% -4.38% -1.75%
Net Income Q/Q Growth
0.00% 0.00% -14.35% -1.15% -5.58% -1.92%
EPS Q/Q Growth
0.00% 0.00% -3.92% 41.94% -52.08% 6.06%
Operating Cash Flow Q/Q Growth
0.00% -228.25% -5.45% 0.80% -9.82% 8.18%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -3.72% -8.74% 2.25%
Invested Capital Q/Q Growth
0.00% 0.00% -50.80% 0.00% 25.23% -22.55%
Profitability Metrics
- - - - - -
Gross Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
135.53% 195.67% 99.49% 95.59% 97.76% 99.42%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
22.32% -102.68% -164.24% -159.89% -221.11% -987.32%
Cash Return on Invested Capital (CROIC)
0.00% -1,069.50% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
22.32% -102.68% -164.24% -159.89% -221.11% -987.32%
Return on Equity Simple (ROE_SIMPLE)
22.32% -33.02% -546.00% -91.86% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.55 -1.60 -9.12 -11 -14 -15
NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
12.09% -63.41% -45.76% -39.62% -59.54% -184.04%
Return On Investment Capital (ROIC_SIMPLE)
- - - -67.26% -841.65% -568.47%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-0.79 -2.26 -13 -15 -20 -21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.76 -2.26 -13 -15 -20 -21
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 1.79 16.45 3.88 37.08 31.76
Price to Tangible Book Value (P/TBV)
0.00 1.79 16.45 3.88 37.08 31.76
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 49.83 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
-0.90 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.89 -1.03 -1.06 -1.08 -1.06 -1.59
Leverage Ratio
-0.01 1.63 1.14 1.16 1.16 2.14
Compound Leverage Factor
-0.01 3.19 1.14 1.11 1.13 2.13
Debt to Total Capital
-876.53% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
-876.53% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
976.53% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
-5.65 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
-5.62 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-7.79 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
-7.74 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
-293.18 24.24 -3.55 26.21 -20.98 -14.85
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
0.01 23.81 2.43 14.09 1.71 1.45
Quick Ratio
0.01 22.44 2.16 13.56 1.47 1.35
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2.33 -7.68 -12 -13 -14
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% -4,723.83% -7,199.50% -2,331.33%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-2.14 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-2.14 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - -
Invested Capital
-0.51 0.22 -1.22 -0.25 -0.72 -1.78
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
0.00 0.73 -1.44 0.97 -0.47 -1.05
Enterprise Value (EV)
21 11 35 46 59 78
Market Capitalization
17 24 39 62 61 83
Book Value per Share
($1.31) $1.72 $0.30 $0.61 $0.06 $0.08
Tangible Book Value per Share
($1.31) $1.72 $0.30 $0.61 $0.06 $0.08
Total Capital
-0.49 13 2.37 16 1.65 2.60
Total Debt
4.30 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
4.27 -13 -3.59 -16 -2.38 -4.38
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.26 0.20 0.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.51 0.22 -1.22 -0.56 -1.23 -2.94
Debt-free Net Working Capital (DFNWC)
-0.49 13 2.37 16 1.15 1.45
Net Working Capital (NWC)
-4.79 13 2.37 16 1.15 1.45
Net Nonoperating Expense (NNE)
0.52 2.83 3.84 3.92 5.53 6.22
Net Nonoperating Obligations (NNO)
4.27 -13 -3.59 -16 -2.38 -4.38
Total Depreciation and Amortization (D&A)
0.03 0.00 0.00 0.00 0.01 0.04
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 ($1.03) ($1.59) ($0.72) ($0.73) ($0.62)
Adjusted Weighted Average Basic Shares Outstanding
0.00 4.28M 8.17M 20.33M 26.65M 33.71M
Adjusted Diluted Earnings per Share
$0.00 ($1.03) ($1.59) ($0.72) ($0.73) ($0.62)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 4.28M 8.17M 20.33M 26.65M 33.71M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 7.96M 8.23M 26.33M 33.73M 41.09M
Normalized Net Operating Profit after Tax (NOPAT)
-0.55 -1.60 -9.12 -11 -14 -15
Normalized NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-2.81 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-1.97 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-2.81 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-1.97 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for HeartBeam

This table displays calculated financial ratios and metrics derived from HeartBeam's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
26,329,032.00 26,329,032.00 26,562,111.00 26,665,470.00 33,725,467.00 33,806,786.00 34,311,589.00 34,443,563.00 41,087,871.00 55,506,835.00 56,349,171.00
DEI Adjusted Shares Outstanding
26,329,032.00 26,329,032.00 26,562,111.00 26,665,470.00 33,725,467.00 33,806,786.00 34,311,589.00 34,443,563.00 41,087,871.00 55,506,835.00 56,349,171.00
DEI Earnings Per Adjusted Shares Outstanding
-0.17 -0.19 -0.19 -0.18 -0.16 -0.15 -0.15 -0.15 -0.11 -0.09 -0.05
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
-15.11% -53.68% -35.64% -20.15% -14.90% 1.20% -4.20% -7.17% 14.64% -0.12% 43.14%
EBIT Growth
-15.11% -53.68% -35.64% -20.32% -15.05% 1.04% -4.36% -7.36% 14.32% -1.09% 41.92%
NOPAT Growth
-15.11% -53.68% -35.64% -20.32% -15.05% 1.04% -4.36% -7.36% 14.32% -1.09% 34.65%
Net Income Growth
-11.36% -57.13% -43.49% -26.50% -19.06% -0.36% -5.54% -8.05% 14.30% -1.31% 42.72%
EPS Growth
66.00% -18.75% -46.15% -357.14% -5.88% 21.05% 21.05% 22.22% 33.33% 33.33% 66.67%
Operating Cash Flow Growth
-11.21% 11.76% -57.58% -45.28% -29.28% 2.96% 4.42% 30.01% 19.37% 2.99% 18.10%
Free Cash Flow Firm Growth
-14,805.85% -44.48% 24.63% 22.23% 34.64% 8.38% -24.74% 10.98% 24.42% -25.26% -34.13%
Invested Capital Growth
94.59% -62.23% 0.00% -186.90% -521.00% -93.13% -49.95% -145.78% -126.09% 37.43% 130.97%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-16.43% -6.40% 0.41% 2.60% -11.34% 8.51% -5.03% -0.17% 11.32% -7.31% 40.34%
EBIT Q/Q Growth
-16.43% -6.40% 0.41% 2.47% -11.33% 8.48% -5.02% -0.34% 11.15% -7.97% 39.65%
NOPAT Q/Q Growth
-16.43% -6.40% 0.41% 2.47% -11.33% 8.48% -5.02% -0.34% 11.15% -7.97% 32.11%
Net Income Q/Q Growth
-18.74% -7.60% -0.46% 1.45% -11.76% 9.30% -5.65% -0.89% 11.35% -7.21% 40.27%
EPS Q/Q Growth
-342.86% -11.76% 0.00% 5.26% 0.00% 16.67% 0.00% 6.67% 14.29% 16.67% 50.00%
Operating Cash Flow Q/Q Growth
-21.17% -2.51% 6.87% -25.59% -7.83% 23.05% 8.27% 8.04% -24.23% 7.42% 22.56%
Free Cash Flow Firm Q/Q Growth
-32.61% 33.50% 23.86% -15.83% -11.44% 6.78% -3.67% 17.34% 5.39% -54.49% -11.01%
Invested Capital Q/Q Growth
60.32% -351.00% -114.41% 25.23% 14.11% -40.26% -66.48% -22.55% 20.99% 61.18% 182.39%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
96.28% 97.37% 98.22% 99.25% 99.64% 98.75% 99.34% 99.89% 99.66% 98.96% 97.95%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-258.74% -113.62% -383.67% -221.11% -202.58% -315.70% -792.01% -987.32% -495.61% -328.44% -521.71%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -3,318.51%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
-258.74% -113.62% -383.67% -221.11% -202.58% -315.70% -792.01% -987.32% -495.61% -328.44% -521.71%
Return on Equity Simple (ROE_SIMPLE)
-120.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.35 -3.56 -3.55 -3.46 -3.85 -3.53 -3.70 -3.72 -3.30 -3.56 -2.42
NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-18.45% -9.14% -49.61% -15.58% -15.69% -20.38% -40.71% -46.96% -27.46% -21.41% -14.90%
Return On Investment Capital (ROIC_SIMPLE)
-26.71% -40.93% -73.91% -209.24% -51.17% -84.31% -912.07% -142.74% -519.87% -43.59% -37.15%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-4.78 -5.09 -5.07 -4.94 -5.50 -5.04 -5.29 -5.31 -4.72 -5.09 -3.07
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-4.78 -5.09 -5.07 -4.94 -5.50 -5.03 -5.28 -5.29 -4.69 -5.04 -3.00
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.58 7.77 12.84 37.08 9.00 10.10 139.44 31.76 78.94 5.09 3.17
Price to Tangible Book Value (P/TBV)
4.58 7.77 12.84 37.08 9.00 10.10 139.44 31.76 78.94 5.09 3.17
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 32.50
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.17 -1.02 -1.20 -1.06 -1.04 -1.10 -1.46 -1.59 -1.25 -1.11 -1.14
Leverage Ratio
1.29 0.93 1.39 1.16 1.13 1.25 1.83 2.14 1.60 1.34 1.55
Compound Leverage Factor
1.24 0.91 1.36 1.15 1.13 1.23 1.82 2.14 1.59 1.33 1.52
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
27.05 21.50 7.38 -5.92 15.21 -3.59 -27.50 -5.91 -24.31 -2.14 -7.42
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
12.07 6.83 3.31 1.71 5.46 2.98 0.86 1.45 0.74 3.66 4.64
Quick Ratio
11.52 6.45 3.11 1.47 5.16 2.81 0.75 1.35 0.62 3.55 4.47
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-5.10 -3.39 -2.58 -2.99 -3.33 -3.11 -3.22 -2.66 -2.52 -3.89 -4.32
Operating Cash Flow to CapEx
-3,935.23% -35,500.00% -3,209.71% 0.00% -223,850.00% -3,445.00% -3,853.66% -698.56% -1,467.48% -1,342.17% -3,750.72%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-0.10 -0.45 -0.97 -0.72 -0.62 -0.87 -1.45 -1.78 -1.40 -0.55 0.45
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
1.75 -0.17 -0.97 -0.47 -0.52 -0.42 -0.48 -1.05 -0.78 0.33 1.90
Enterprise Value (EV)
45 59 56 59 60 37 55 78 48 33 15
Market Capitalization
57 68 62 61 68 42 57 83 50 42 21
Book Value per Share
$0.48 $0.33 $0.18 $0.06 $0.22 $0.12 $0.01 $0.08 $0.02 $0.15 $0.12
Tangible Book Value per Share
$0.48 $0.33 $0.18 $0.06 $0.22 $0.12 $0.01 $0.08 $0.02 $0.15 $0.12
Total Capital
13 8.71 4.80 1.65 7.53 4.18 0.41 2.60 0.64 8.18 6.51
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-13 -9.16 -5.77 -2.38 -8.15 -5.05 -1.86 -4.38 -2.04 -8.72 -6.07
Capital Expenditures (CapEx)
0.09 0.01 0.10 0.00 0.00 0.10 0.08 0.42 0.25 0.25 0.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.50 -0.88 -1.48 -1.23 -1.12 -1.49 -2.20 -2.94 -2.90 -2.19 -1.12
Debt-free Net Working Capital (DFNWC)
12 8.28 4.29 1.15 7.03 3.56 -0.34 1.45 -0.86 6.54 4.94
Net Working Capital (NWC)
12 8.28 4.29 1.15 7.03 3.56 -0.34 1.45 -0.86 6.54 4.94
Net Nonoperating Expense (NNE)
1.26 1.39 1.43 1.45 1.63 1.45 1.55 1.59 1.40 1.47 0.59
Net Nonoperating Obligations (NNO)
-13 -9.16 -5.77 -2.38 -8.15 -5.05 -1.86 -4.38 -2.04 -8.72 -6.07
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.02 0.02 0.06 0.07
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.17) ($0.19) ($0.19) ($0.18) ($0.18) ($0.15) ($0.15) ($0.14) ($0.12) ($0.10) ($0.05)
Adjusted Weighted Average Basic Shares Outstanding
26.51M 26.57M 26.75M 26.65M 30.38M 33.83M 34.40M 33.71M 40.59M 52.77M 57.20M
Adjusted Diluted Earnings per Share
($0.17) ($0.19) ($0.19) ($0.18) ($0.18) ($0.15) ($0.15) ($0.14) ($0.12) ($0.10) ($0.05)
Adjusted Weighted Average Diluted Shares Outstanding
26.51M 26.57M 26.75M 26.65M 30.38M 33.83M 34.40M 33.71M 40.59M 52.77M 57.20M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
26.33M 26.56M 26.67M 33.73M 33.81M 34.31M 34.44M 41.09M 55.51M 56.35M 63.31M
Normalized Net Operating Profit after Tax (NOPAT)
-3.35 -3.56 -3.55 -3.46 -3.85 -3.53 -3.70 -3.72 -3.30 -3.56 -2.42
Normalized NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

HeartBeam (NASDAQ:BEAT) remains a pre-revenue company with no reported revenue in any of the periods provided. The company continues to fund product development primarily through equity issuance while recording substantial operating losses and negative operating cash flow.

  • Liquidity improved sharply in Q2 2026. Cash and equivalents increased to $8.7 million from $2.0 million at the end of Q1, largely because HeartBeam raised approximately $10.3 million through common equity issuance.
  • The balance sheet became less leveraged in the latest quarter. Total liabilities declined to $2.5 million from $3.3 million in Q1 2026, while total equity increased to $8.2 million from just $635,000.
  • Current liquidity is substantially stronger than earlier periods. Q2 current assets of $9.0 million compared with current liabilities of $2.5 million, implying a current ratio of roughly 3.7, versus less than 1.0 in Q1 2026.
  • Research and development spending has moderated over the longer period. R&D expense declined to $2.3 million in Q2 2026 from $3.5 million in Q1 2025, although the latest quarter showed a modest increase from Q1 2026.
  • HeartBeam continues to invest in its infrastructure. Capital expenditures were $249,000 in Q2 2026, and net property, plant and equipment rose to $1.6 million from $694,000 in Q3 2025. This may support commercialization, but the financial benefit has not yet appeared in revenue.
  • Interest income provides a small offset to operating losses. Interest and investment income increased to $53,000 in Q2 2026 from $16,000 in Q1 and $3,000 in Q4 2025, reflecting the company’s cash balances, but it remains immaterial relative to quarterly expenses.
  • Revenue remains at zero. HeartBeam reported no revenue, cost of revenue or gross profit in the disclosed quarters, leaving the company without an operating source of cash and making future commercialization a critical investment milestone.
  • Losses remain persistent and substantial. Q2 2026 net loss was $5.0 million, compared with $4.7 million in Q1 2026 and $5.0 million in Q2 2025. Operating expenses rose to $5.1 million from $4.7 million sequentially, led by a jump in selling, general and administrative expense to $2.8 million.
  • Operating cash flow remains heavily negative. HeartBeam used $3.3 million in operating cash during Q2 2026, following cash outflows of $3.6 million in Q1 2026 and $2.9 million in Q4 2025. At the recent quarterly burn rate, Q2 cash alone represents only a limited number of quarters of funding absent additional financing or revenue.
  • Shareholder dilution is a major risk. Weighted-average basic shares outstanding increased to 52.8 million in Q2 2026 from 40.6 million in Q1 and 33.8 million in Q2 2025. Repeated equity raises—including approximately $10.3 million in Q2 2026—have improved liquidity but increased the ownership dilution faced by existing investors.

Overall, HeartBeam’s latest balance sheet is stronger because of the Q2 equity raise, and the company has no significant long-term debt in the supplied data. However, the improvement is financing-driven rather than operating-driven. Until revenue begins, investors should expect continued cash burn, recurring losses and a meaningful possibility of additional equity financing.

11/18/26 07:13 AM ETAI Generated. May Contain Errors.

HeartBeam Financials - Frequently Asked Questions

According to the most recent income statement we have on file, HeartBeam's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

HeartBeam's net income appears to be on a downward trend, with a most recent value of -$21.02 million in 2025, falling from -$1.07 million in 2020. The previous period was -$19.45 million in 2024. See where experts think HeartBeam is headed by visiting HeartBeam's forecast page.

HeartBeam's total operating income in 2025 was -$21.14 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $21.14 million

Over the last 5 years, HeartBeam's total revenue changed from $0.00 in 2020 to $0.00 in 2025, a change of 0.0%.

In the past 10 quarters, HeartBeam's cash and equivalents has ranged from $1.86 million in Q3 2025 to $12.64 million in Q1 2024, and is currently $6.07 million as of their latest financial filing in Q3 2026.

HeartBeam had total debt of $0.00 at the end of 2025, compared with none in 2024, and a 100.0% decrease since 2020.

Over the last 5 years, HeartBeam's book value per share changed from -1.31 in 2020 to 0.08 in 2025.



Financial statements for NASDAQ:BEAT last updated on 11/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners